| NEWS
news T
he AmericAn Society for Aesthetic Plastic Surgery (ASAPS) has announced that many consumers are still unaware of the risks associated with aesthetic procedures performed
by unlicensed practitioners. reports from Las Vegas and
Philadelphia document unsuspecting patients suffering from pain and disfigurement and in the two cases, death, when women had their buttocks injected with
unknown
substances. injectable fillers to enhance the bust, hips, buttocks or face are frequently administered in non‑clinical settings by amateur or unlicensed
practitioners.
Unsuspecting patients have been injected with materials such as silicone, baby oil, and those with no safety or efficacy record. 'We desperately need more consumer education on this topic ... Patients may be lured in by
Lexington International, LLC has announced the successful completion of two clinical studies of the HairMax LaserComb, proving the efficacy and safety of three new devices for the treatment of androgenetic alopecia. The analysis showed that 95.4% of participants experienced hair growth. Furthermore, the average increases in hair count for participants in the
A round-up of news stories in the aesthetic and anti-ageing medicine industry
phoNy procEdurEWArNiNg
ASApS warns of the dangers and risks of procedures performed by unlicensed practitioners
inexpensive prices and unrealistic claims. Patients think they are getting a bargain, but they are actually putting their health and lives at risk and they may not even know it,' saidfelmontf.eaves, iii, President of the Aesthetic Society. Patients can make safe choices when seeking cosmetic procedures by selecting qualified physicians who perform or oversee procedures in appropriate settings. in most cases, cosmetic
procedures offered in non‑medical settings, such as homes, hotels and beauty salons are not performed by qualified individuals and may involve the use of illegal or unknown substances. Patients should never choose a doctor solely on
the basis of lower cost. 'We hear very sad and frustrating
stories of patients being taken advantage of by phony doctors and illegal procedures. Patients are being scammed and exposed to great harm,' said Dr eaves.
Advancements in oral implants
New materials and technologies offer implant dentistry to more patients. Fibre-reinforced composite is a new material that promises advantages for use in oral and craniofacial applications, as well as orthopaedics.. A study published in the Journal of
Oral Implantology compared fibre-reinforced composite and titanium implants. Researchers analysed how the materials affect stress and strain on the implant and bone tissue. They also compared interfacial stresses between the materials under 3 directions of load. Distribution of stress and strain
to the jawbone is significantly changed after reconstruction with oral implants. How an implant using fibre-reinforced composite reacts has not yet been well biomechanical
tested. This connection
between implant and bone can be different for each patient and is hard to measure. This study used a three- dimensional finite element model constructed from a mandibular bone and an implant to test these materials. Although variances were observed for both, the composite performed well.
NEW MILESTONES IN HAIR GROWTH AND FDA CLEARANCE two double-blind,
HairMax LaserComb group was 20.4 hairs/cm2
, which is considered
medically and scientifically significant. None of the participants in the studies experienced any serious side-effects. Based in part on submission of clinical results, the FDA Granted Class II Clearance 510(k) K103368 of these medical devices for sale in the USA for the 'Treatment of Hair Loss and
Promotion of Hair Growth' in males. The
device-controlled multi-centre
studies were conducted by Zoe Draelos, David Goldberg, Michael Jarrett, and Abe Mercadis, under Good Clinical Practice guidelines and Institutional Review Board approval. Submission of these data was a major component of the FDA filing and was a key factor in the
agency's decision to clear the HairMax LaserComb. The clearance further validates the HairMax as a non-drug option for treating hereditary hair loss in males. Since 2001, Lexington has
completed a total of seven clinical studies with 460 subjects and all of the studies have demonstrated the efficacy and safety of the HairMax LaserComb.
prime-journal.com | May 2011 ❚ 9
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84